Myocardial Ischemia National Audit Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A registry trial of SGLT-2 inhibition in low-risk patients after an MI showed some benefit in preventing future events, but a larger study would be warranted to further validate the signal.

United kingdomUppsala lanUnited statesStephend wiviottStefan jamesHarvard medical schoolUppsala universityYork heart associationMyocardial ischemia national auditRisk patientsMyocardial ischemia national audit projectMyocardial infarctionSglt2 inhibitorsOdium glucose transporter 2 inhibitorsOdium glucose co transporter 2 inhibitorsSodium glucose cotransporter 2 inhibitors